Speaker illustration

Mr Jore Van Wauwe

KU Leuven, Leuven (Belgium)

Jore Van Wauwe is a PhD researcher at the Cardiovascular Sciences Department, KU Leuven, Belgium. After earning his MS degree in Biosciences Engineering, he joined Dr Aernout Luttun’s team to focus on drug screening for cardiomyopathies using mouse and zebrafish models. For the latter, he went on a 6-month internship in Dr Calum MacRae’s lab (Harvard Medical School, Boston). Back in Leuven, he engaged in multiple projects within the host Department, through his acquired skills in 3D-echocardiography in mice. During his PhD tenure, he developed a particular interest in (epi)genomics and transcriptomics. After obtaining his PhD degree, Jore aspires a career in (academic) science driven by the belief that precision medicine is becoming a crucial aspect of improving human (cardiovascular) health.

Combined deletion of PR-domain containing 16 (Prdm16) in cardiomyocyte and non-cardiomyocyte lineages results in spontaneous early-onset lethality and progressive left ventricular dysfunction in mice.

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiomyopathies

Session: Basic science e-posters


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb